← Back to Search

Device

Transcranial Magnetic Stimulation for Tourette Syndrome (STOP-TIC Trial)

N/A

Recruiting

Led By Jessica Frey, MD

Research Sponsored by West Virginia University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, an average of 3 months

Awards & highlights

STOP-TIC Trial Summary

This trial will study if using a magnetic stimulation followed by therapy can reduce tics in adults with Tourette's Syndrome. It will compare changes in tic frequency/severity + neurophysiological changes.

Who is the study for?

Adults over 18 with Tourette Syndrome and moderate tic severity can join this study. It's not for those with metal in their brain, pregnant individuals, people with seizures or epilepsy history, anyone who can't have an fMRI, or if another condition prevents them from doing CBIT therapy.Check my eligibility

What is being tested?

The trial is testing whether a technique called rTMS enhances the effects of a tic treatment known as CBIT in adults with Tourette's. Participants are randomly assigned to get either real rTMS or a pretend version before starting eight sessions of CBIT.See study design

What are the potential side effects?

rTMS may cause discomfort at the stimulation site, headache, lightheadedness, or twitching facial muscles during treatment. Rarely it could induce seizures but is generally considered safe.

STOP-TIC Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, an average of 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, an average of 3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Modified Rush Videotape Tic Rating Scale (mRVTRS)

Yale Global Tic Severity Scale (YGTSS)

STOP-TIC Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: Active rTMSActive Control1 Intervention

Patients receiving active rTMS

Group II: Sham rTMSPlacebo Group1 Intervention

Patients receiving sham rTMS

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of FloridaOTHER

1,341 Previous Clinical Trials

715,626 Total Patients Enrolled

7 Trials studying Tourette Syndrome

122 Patients Enrolled for Tourette Syndrome

Tourette Association of AmericaOTHER

11 Previous Clinical Trials

506 Total Patients Enrolled

11 Trials studying Tourette Syndrome

506 Patients Enrolled for Tourette Syndrome

West Virginia UniversityLead Sponsor

176 Previous Clinical Trials

60,194 Total Patients Enrolled

Media Library

Transcranial Magnetic Stimulation (Device) Clinical Trial Eligibility Overview. Trial Name: NCT05705999 — N/A

Tourette Syndrome Research Study Groups: Sham rTMS, Active rTMS

Tourette Syndrome Clinical Trial 2023: Transcranial Magnetic Stimulation Highlights & Side Effects. Trial Name: NCT05705999 — N/A

Transcranial Magnetic Stimulation (Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05705999 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any remaining vacancies for individuals to join this medical experiment?

"According to clinicaltrials.gov, this medical study is presently inviting participants to join their trial. It was first launched on August 1st 2023 and has been updated most recently on July 24th of the same year."

Answered by AI

Does the age requirement for this medical study extend to those who are younger than thirty?

"This trial is open to adults aged 18-100. There are also 17 clinical trials specifically for minors below the age of 18 and 16 studies geared towards seniors older than 65 years old."

Answered by AI

Do I fit the criteria necessary to take part in this medical experiment?

"The clinical trial requires applicants to be between 18 and 100 years of age, have tourette syndrome, and is currently searching for roughly 20 participants."

Answered by AI

What is the upper limit on how many participants are taking part in this medical investigation?

"Affirmative. Clinicaltrials.gov data states that this medical investigation, initially posted on August 1st 2023, is actively searching for participants. A maximum of twenty individuals need to be recruited from one location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Strengthening Tourette Treatment OPtions Using TMS to Improve CBIT, a Double-blind, Randomized, Controlled Study

Jessica Frey 2024. "Strengthening Tourette Treatment OPtions Using TMS to Improve CBIT, a Double-blind, Randomized, Controlled Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05705999.

All > Tourette Syndrome